Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

FDA delivers first report on foreign offices to Congress. Agency denies citizen petition on IOM 510(k) panel. More regulatory briefs.

You may also be interested in...



Special-Controls Guidelines Address Tryptase Tests To Aid Mastocytosis Diagnosis

Following on its 2012 de novo reclassification of tryptase assays to help diagnose systemic mastocytosis, FDA issued special-control guidelines Sept. 18.

FDA To Survey Clinicians About Adding “Highlights” Section To Device Labeling

FDA wants to know what information physicians, nurses and technicians would like to see in a shortened "quick guide" version of labeling as part of an effort that could result in more standardized device labeling.

Regulatory News In Brief

Radiological health post-market offices moving to OIVD. FDA issues global engagement report. More regulatory news.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031022

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel